# US Pharmaceutical Waste Management Market

> US Pharmaceutical Waste Management Market Research Report: Size, Share, Trend Analysis By Nature of Waste (Non-hazardous Pharmaceutical waste, Hazardous Pharmaceutical Waste), By Types of Waste (Over the counter Waste, Non-controlled Prescription Drugs, Controlled Drugs, Hazardous Drugs) and By Source of Waste Generation (Hospitals, Clinics & Physicians' Offices, Pharmaceutical & Biotechnology Companies, Pharmacies) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.17%
- **2024:** $ 275.27 Million
- **2025:** $ 295.01 Million
- **2035:** $ 589.73 Million
- **Key Players:** Veolia (FR), Stericycle (US), Clean Harbors (US), Waste Management (US), Republic Services (US), SUEZ (FR), Covanta (US), GFL Environmental (CA), Remondis (DE)

**Report ID:** MRFR/Pharma/17394-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-pharmaceutical-waste-management-market-18940

---

## Market Summary

## **US Pharmaceutical Waste Management Market Overview**

As per MRFR analysis, the US Pharmaceutical Waste Management Market Size was estimated at 247.8 (USD Million) in 2023. The US Pharmaceutical Waste Management Market Industry is expected to grow from 254.1(USD Million) in 2024 to 641.8 (USD Million) by 2035. The US Pharmaceutical Waste Management Market CAGR (growth rate) is expected to be around 8.788% during the forecast period (2025 - 2035).

### **Key US Pharmaceutical Waste Management Market Trends Highlighted**

The US Pharmaceutical Waste Management Market is currently influenced by several significant trends that reflect growing concerns over environmental sustainability and public health. Key market drivers include stringent regulations imposed by the Environmental Protection Agency (EPA) and state-level agencies, mandating proper disposal methods for hazardous pharmaceutical waste. 

These regulations encourage healthcare facilities, including hospitals and pharmacies, to adopt comprehensive waste management strategies that minimize environmental impact. Additionally, the rise in the volume of pharmaceutical waste generated, predominately due to the increase in prescription medications, has necessitated improved waste handling processes.

Opportunities to be explored in this market include the development of advanced waste-to-energy technologies and innovative recycling solutions that can further mitigate waste while recovering valuable materials. Companies are also focusing on educational campaigns for proper drug disposal methods to increase community involvement, thus reducing the risk of pharmaceuticals entering the water supply. 

Trends in recent times indicate a shift towards digitization in waste management systems, with healthcare facilities investing in software solutions for better tracking and reporting of waste disposal metrics. Such technology facilitates compliance with regulatory requirements and enhances operational efficiency. Increasing awareness around the dangers of improper pharmaceutical disposal is pushing for collaborative initiatives between manufacturers, healthcare providers, and governmental bodies. 

Overall, the US Pharmaceutical Waste Management Market is evolving rapidly, reflecting a urgent need for enhanced practices aimed at environmental protection and public health safety.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Pharmaceutical Waste Management Market Drivers**

### **Increasing Regulations on Pharmaceutical Waste Disposal**

In the United States, there has been a significant increase in federal and state regulations governing the disposal of pharmaceutical waste. The Environmental Protection Agency (EPA) and various state agencies have implemented strict guidelines as part of the Resource Conservation and Recovery Act, mandating that healthcare providers properly manage pharmaceutical waste. This regulatory framework is becoming increasingly stringent, with fines and penalties for non-compliance. For instance, a 2021 report indicated that nearly 50 percent of hospitals faced non-compliance issues with hazardous waste regulations, encouraging them to seek out efficient waste management solutions.

As regulations continue to evolve, the US Pharmaceutical Waste Management Market Industry is expected to see a considerable surge in demand for compliant waste management services.

### **Growing Awareness of Environmental Impact**

There is a growing awareness concerning the environmental impact associated with improper disposal of pharmaceutical waste among both healthcare providers and consumers in the United States. According to a 2020 study published in the Journal of the American Medical Association, an estimated 90 tons of unused or expired pharmaceuticals are generated by hospitals and clinics in the US each day. Public pressure and advocacy groups, such as the National Institute of Health, are increasingly emphasizing the need for responsible disposal methods to prevent contamination in water sources and ecosystems.

This heightened awareness is driving healthcare facilities to adopt better waste management practices, directly contributing to the growth of the US Pharmaceutical Waste Management Market Industry.

### **Rapid Growth in Biopharmaceutical Development**

The biopharmaceutical sector in the United States has been expanding rapidly, with an estimated growth rate of approximately 9 percent annually over the next few years. As more biopharmaceutical products enter the market, there is a corresponding increase in pharmaceutical waste generated from clinical trials and production processes. Organizations such as the Biotechnology Innovation Organization play a crucial role in facilitating this growth, resulting in heightened scrutiny surrounding the disposal of these products.

Given that improper disposal can lead to environmental hazards, this trend is pushing healthcare providers and pharmaceutical companies to implement more efficient waste management solutions, thereby boosting the US Pharmaceutical Waste Management Market Industry.

## **US Pharmaceutical Waste Management Market Segment Insights**

### **Pharmaceutical Waste Management Market Nature of Waste Insights**

The Nature of Waste segment within the US Pharmaceutical Waste Management Market plays a pivotal role in how pharmaceutical waste is handled and processed. This segment is primarily categorized into two main types: Non-hazardous Pharmaceutical Waste and Hazardous Pharmaceutical Waste. Non-hazardous Pharmaceutical Waste typically includes items like empty medication bottles, packaging materials, and other non-contaminated products, which necessitate simpler disposal methods. This category is essential for promoting environmentally friendly practices and supports recycling initiatives that aim to reduce landfill waste.

On the other hand, Hazardous Pharmaceutical Waste encompasses potentially harmful substances that can pose risks to public health and the environment if not properly managed. This type of waste includes expired medications, contaminated sharps, and other toxic substances requiring specialized disposal methods to mitigate risks. The significance of Hazardous Pharmaceutical Waste cannot be overstated, as improper disposal can lead to soil and water contamination, affecting ecosystems and public health. Regulatory compliance is critical in managing both categories of waste, and various federal and state regulations dictate how to process these materials safely.

The US government continues to implement stringent guidelines to ensure the safe management of pharmaceutical waste, reflecting the need for effective strategies to protect the environment and human health. As the healthcare sector evolves, the demand for comprehensive waste management solutions in the pharmaceutical industry is anticipated to grow, driven by increased regulations, awareness about environmental impact, and the need for efficient, safe disposal methods.

The growth in this market segment is accompanied by the development of innovative technologies aimed at improving waste segregation, collection, and disposal practices, enabling healthcare facilities to manage their waste more effectively while adhering to regulatory standards. The insights within the Nature of Waste segment highlight the complexities and importance of proper pharmaceutical waste management in ensuring a sustainable and eco-conscious future for the US healthcare industry.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Pharmaceutical Waste Management Market Type of Waste Insights**

The US Pharmaceutical Waste Management Market focuses on the management of various types of waste generated within the pharmaceutical sector, which includes Over the Counter Waste, Non-controlled Prescription Drugs, Controlled Drugs, and Hazardous Drugs. Over the Counter Waste, a significant component, includes products widely available without prescriptions, making its proper disposal essential to prevent environmental contamination and misuse. Non-controlled Prescription Drugs represent a notable portion as well, encompassing prescriptions that are not classified as controlled substances but still require careful management to mitigate potential health risks.

Controlled Drugs, which are strictly regulated due to their potential for abuse, present unique challenges in waste management that necessitate stringent practices to ensure compliance with regulations and safeguard public health. Hazardous Drugs, known for their toxicity and potential harm, demand specialized waste management solutions to protect healthcare workers and the environment. The increasing awareness of safe disposal methods and regulations is driving innovations in waste management processes, creating opportunities for growth in the market. Understanding the dynamics of these waste types is crucial for mitigating risks and enhancing sustainability within the US pharmaceutical industry.

### **Pharmaceutical Waste Management Market Source of Waste Generation Insights**

The Source of Waste Generation segment in the US Pharmaceutical Waste Management Market encompasses various entities such as Hospitals, Clinics and Physicians’ Offices, Pharmaceutical and Biotechnology Companies, and Pharmacies. Hospitals represent a significant portion of pharmaceutical waste generation as they handle various medications and treatments, resulting in large volumes of waste that need proper disposal to comply with regulatory standards. Clinics and Physicians’ Offices contribute to this waste primarily through unused or expired medications, making their role crucial in ensuring proper waste management practices are implemented.

Pharmaceutical and Biotechnology Companies are also essential, as they generate waste through production processes and product development, reinforcing the need for effective waste management strategies to mitigate environmental impact. Pharmacies further add to the landscape by generating waste from returned medications and expired stock, emphasizing the overall importance of the Source of Waste Generation segment in maintaining public health and environmental safety. This segment is driven by increasing regulations, rising awareness about the environmental impacts of pharmaceutical waste, and a growing need for sustainable waste management solutions across the industry.

In summary, the diversity of waste sources underlines the significance of tailored waste management approaches to address the unique challenges faced by each entity.

## **US Pharmaceutical Waste Management Market Key Players and Competitive Insights**

The US Pharmaceutical Waste Management Market has gained significant traction due to increasing regulatory scrutiny regarding the disposal of hazardous waste and the growing focus on sustainability. The competitive landscape is shaped by various key players who specialize in providing waste management solutions tailored to the needs of healthcare providers, pharmacies, and pharmaceutical manufacturers. These companies are engaged in the development of innovative technologies and services to efficiently manage pharmaceutical waste through environmentally-conscious practices.

The rising incidence of improper disposal of pharmaceuticals has prompted the industry to evolve, with heightened emphasis on compliance with federal and state regulations, thereby influencing competitive strategies. Furthermore, effective disposal methods that mitigate environmental impact while ensuring safety for public health have become focal points in shaping market dynamics.

MediWaste stands out in the US Pharmaceutical Waste Management Market owing to its comprehensive approach to waste disposal and management services. The company is recognized for its extensive knowledge of federal and state regulations, which enables it to assist healthcare professionals in achieving compliance while minimizing risks associated with hazardous waste. MediWaste's strong market presence is reinforced by its commitment to offering tailored solutions that cater specifically to the diverse needs of its clients. The company leverages advanced technologies to provide safe and efficient waste disposal, thereby enhancing operational efficiencies for healthcare providers.

Additionally, MediWaste's focus on customer relationships and reliable service delivery contributes to its competitive edge, allowing it to sustain a strong reputation within the market.

Covanta poses a formidable presence in the US Pharmaceutical Waste Management Market, known for its advanced waste-to-energy solutions and integrated waste management services. Covanta specializes in treating pharmaceutical waste by utilizing high-temperature incineration methods that ensure safe and compliant disposal. The company's key offerings include thermal treatment solutions that significantly reduce the volume of hazardous waste while converting it into energy. 

Covanta has established a strong nationwide infrastructure that facilitates effective waste logistics and service delivery. Its competitive advantages are further accentuated by strategic mergers and acquisitions, which have expanded its operational capabilities and market reach. The commitment of Covanta to sustainable waste management practices, combined with its state-of-the-art facilities and expertise in environmental regulations, positions it as a leader in the US pharmaceutical waste management space, setting industry benchmarks for safety, efficacy, and compliance.

### **Key Companies in the US Pharmaceutical Waste Management Market Include**

## **US Pharmaceutical Waste Management Market Industry Developments**

Recent developments in the US Pharmaceutical Waste Management Market have seen a surge in regulatory scrutiny and innovations to improve waste management processes. With increasing awareness regarding the environmental impact of pharmaceutical waste, companies like MediWaste, Stericycle, and BioMedical Waste Solutions have been working on advanced waste treatment technologies to enhance compliance with stringent regulations. In terms of mergers and acquisitions, Covanta, a key player, acquired a waste management division that bolstered its capabilities in handling hazardous medical waste in August 2023. 

Additionally, Waste Management expanded its service offerings by acquiring a local medical waste disposal company in June 2023, enhancing its operational footprint. The market has witnessed substantial growth, with valuations for companies like Sharps Compliance and Clean Harbors increasing significantly due to the growing emphasis on sustainability and efficient waste handling. Regulatory bodies, including the Environmental Protection Agency, continue to emphasize the importance of managing pharmaceutical waste, influencing companies to adopt more innovative and environmentally friendly solutions. Market dynamics have been strongly shaped by these factors, ensuring a robust expansion trajectory in the coming years.

Over the past two to three years, the focus on legislative frameworks has only intensified, enhancing accountability across the industry.

## **US Pharmaceutical Waste Management Market Segmentation Insights**

### **Pharmaceutical Waste Management Market Nature of Waste Outlook**

### **Pharmaceutical Waste Management Market Type of Waste Outlook**

### **Pharmaceutical Waste Management Market Source of Waste Generation Outlook**

## Market Drivers

### Increasing Regulatory Scrutiny

The pharmaceutical waste-management market is experiencing heightened regulatory scrutiny as federal and state agencies enforce stricter guidelines for waste disposal. This trend is driven by the need to mitigate environmental risks associated with improper disposal of pharmaceutical products. The Environmental Protection Agency (EPA) has established regulations that mandate proper disposal methods, which has led to a growing demand for compliant waste-management solutions. In 2023, the market was valued at approximately $1.5 billion, with projections indicating a compound annual growth rate (CAGR) of 5.2% through 2030. This regulatory environment compels pharmaceutical companies to invest in effective waste-management strategies, thereby driving market growth.

### Focus on Healthcare Facility Compliance

the emphasis on compliance within healthcare facilities is a pivotal factor driving the pharmaceutical waste market. Hospitals and clinics are increasingly required to adhere to stringent waste disposal regulations to avoid penalties and ensure patient safety. In 2023, approximately 70% of healthcare facilities reported investing in compliance training and waste-management systems to align with federal and state regulations. This focus on compliance not only mitigates legal risks but also enhances the reputation of healthcare providers. As regulatory frameworks continue to evolve, the pharmaceutical waste-management market is expected to benefit from the ongoing commitment of healthcare facilities to maintain compliance and implement effective waste-management practices.

### Rising Awareness of Environmental Impact

There is a growing awareness regarding the environmental impact of pharmaceutical waste, which is significantly influencing the pharmaceutical waste-management market. Stakeholders, including healthcare providers and consumers, are increasingly concerned about the potential harm caused by improper disposal of medications. This awareness has prompted healthcare facilities to adopt more sustainable waste-management practices. In 2024, it was estimated that around 30% of healthcare facilities in the US had implemented advanced waste-management systems to address these concerns. As public consciousness continues to evolve, the demand for innovative solutions in the pharmaceutical waste-management market is likely to increase, fostering further market expansion.

### Growing Demand for Safe Disposal Solutions

The increasing demand for safe disposal solutions is a critical driver of the pharmaceutical waste-management market. As the volume of pharmaceutical products continues to rise, so does the need for effective disposal methods that prevent environmental contamination and public health risks. In 2025, it is anticipated that the market for safe disposal solutions will reach $2 billion, reflecting a growing recognition of the importance of responsible waste management. This demand is particularly pronounced in urban areas, where the concentration of healthcare facilities necessitates robust waste-management strategies. Consequently, companies that offer comprehensive disposal solutions are likely to see significant growth in this evolving market.

### Technological Integration in Waste Management

The integration of advanced technologies in waste management is transforming the pharmaceutical waste-management market. Innovations such as automated waste sorting systems and real-time tracking of waste disposal are becoming more prevalent. These technologies enhance efficiency and compliance with regulatory standards, thereby reducing the risk of environmental contamination. In 2025, it is projected that the market for technology-driven waste solutions will account for approximately 40% of the overall market share. This shift towards technological integration not only streamlines operations but also supports pharmaceutical companies in meeting their sustainability goals, thus propelling market growth.

## Future Outlook

The [Pharmaceutical Waste Management Market](https://www.marketresearchfuture.com/reports/pharmaceutical-waste-management-market-6548) is projected to grow at a 7.17% CAGR from 2025 to 2035, driven by regulatory pressures, technological advancements, and increasing environmental awareness.

**New opportunities:**

- Development of advanced waste tracking software solutions Expansion of eco-friendly disposal technologies Implementation of comprehensive pharmaceutical take-back programs

By 2035, the market is expected to achieve robust growth, driven by innovation and regulatory compliance.

## Segment Insights

### By Nature of Waste: Non-hazardous Pharmaceutical Waste (Largest) vs. Hazardous Pharmaceutical Waste (Fastest-Growing)

The US pharmaceutical waste-management market showcases a varied distribution between non-hazardous and hazardous pharmaceutical waste. Non-hazardous pharmaceutical waste constitutes the largest segment, primarily due to its large volume generated through various healthcare activities. In contrast, hazardous pharmaceutical waste, while smaller in total volume, is gaining a more significant market share as regulatory compliance and safety concerns drive changes in disposal practices.

Growth trends in this segment are influenced by an increasing awareness of environmental impacts and stringent regulations surrounding hazardous waste. The rise of eco-friendly disposal methods and technological advancements in waste management also contribute to the growth of hazardous pharmaceutical waste, marking it as the fastest-growing segment. This growth is projected to continue as stakeholders prioritize sustainable practices and efficient waste management.

Non-hazardous Pharmaceutical Waste (Dominant) vs. Hazardous Pharmaceutical Waste (Emerging)

The non-hazardous pharmaceutical waste segment dominates the US pharmaceutical waste-management market due to the sheer volume generated by healthcare facilities, pharmacies, and households. This type of waste is often easier to manage and dispose of, leading to cost-effective solutions for waste handlers. In contrast, hazardous pharmaceutical waste, which includes expired drugs, contaminated materials, and other toxic substances, is regarded as an emerging market. It requires specialized handling and disposal methods to mitigate environmental and health risks. As regulations tighten, the market is seeing increased investment in technologies and processes designed to ensure safe handling of hazardous waste, positioning it as a critical area of growth within the pharmaceutical waste-management sector.

### By Type of Waste: Controlled Drugs (Largest) vs. Hazardous Drugs (Fastest-Growing)

In the US pharmaceutical waste-management market, the distribution of waste types reveals Controlled Drugs as the largest segment. This category encompasses substances that are heavily regulated due to their potential for abuse and addiction. Following Controlled Drugs, Over the Counter Waste and Non-controlled Prescription Drugs hold significant shares, but they do not match the prominence of Controlled Drugs. Hazardous Drugs, while currently a smaller segment, are gaining traction rapidly. The concern over environmental safety and regulatory compliance is driving this growth.

Growth trends indicate that the demand for Hazardous Drugs management is increasing due to stricter regulations imposed on hazardous materials. This segment is becoming crucial, particularly as awareness rises regarding the environmental impact of improper disposal. Moreover, the rise in healthcare facilities and the consequent increase in pharmaceutical waste are contributing to the escalating need for effective waste-management solutions. The healthcare sector’s focus on sustainability and compliance with legal mandates further fuels the growth of this segment.

Controlled Drugs (Dominant) vs. Hazardous Drugs (Emerging)

Controlled Drugs represent a critical component of the pharmaceutical waste-management landscape, primarily due to their stringent regulations and significant health implications. This segment includes opioids and other substances that require careful oversight during disposal to prevent misuse and environmental harm. On the other hand, Hazardous Drugs are emerging as a vital segment, driven by increased regulatory frameworks addressing safety and environmental impact. While Controlled Drugs dominate the market share, Hazardous Drugs are rapidly evolving with advances in waste treatment technologies and growing awareness among healthcare providers about best practices for disposal. As both segments evolve, their distinct characteristics underscore the complex nature of pharmaceutical waste management.

### By Source of Waste Generation: Hospitals (Largest) vs. Clinics & Physicians' Offices (Fastest-Growing)

In the US pharmaceutical waste-management market, hospitals represent the largest source of waste generation, capturing a significant share due to their extensive operations and high volumes of pharmaceutical use. Clinics and physicians' offices follow, contributing notable levels of waste, although at a smaller scale. Pharmaceutical and biotechnology companies, along with pharmacies, also play crucial roles but account for lesser shares compared to hospitals and clinics.

Growth trends within this segment indicate a shift towards increased waste generation from clinics and physicians' offices, making them the fastest-growing sources. This rise is driven by their expanding services and the increasing prevalence of outpatient treatments. Stringent regulatory requirements and a focus on sustainable waste management are further propelling the need for effective waste disposal solutions across all sectors.

Hospitals (Dominant) vs. Clinics & Physicians' Offices (Emerging)

Hospitals dominate the pharmaceutical waste generation landscape, characterized by their large healthcare facilities that handle substantial quantities of pharmaceuticals across various departments. Their waste often includes hazardous materials, making effective waste management crucial. Conversely, clinics and physicians' offices are emerging as an important segment, particularly as they expand services that result in higher pharmaceutical usage. This growth is accompanied by a greater focus on compliance with waste regulations and sustainable practices. As outpatient services expand, these facilities will likely adapt their waste management strategies to align with the evolving landscape of healthcare waste disposal.

## Competitive Benchmarking

The pharmaceutical waste-management market in the US is characterized by a competitive landscape that is increasingly shaped by regulatory pressures, technological advancements, and a growing emphasis on sustainability. Key players such as Stericycle (US), Clean Harbors (US), and Veolia (FR) are actively positioning themselves to leverage these dynamics. Stericycle (US) has focused on enhancing its service offerings through digital transformation, aiming to streamline operations and improve customer engagement. Clean Harbors (US) emphasizes its commitment to sustainability, integrating eco-friendly practices into its waste management solutions, which resonates well with the evolving expectations of healthcare providers and regulators alike. Meanwhile, Veolia (FR) is pursuing strategic partnerships to expand its footprint in the US market, indicating a trend towards collaborative approaches in addressing complex waste management challenges.The market structure appears moderately fragmented, with several players competing for market share while also collaborating on certain initiatives. Companies are increasingly localizing their operations to optimize supply chains and reduce costs, which may enhance their competitive positioning. The collective influence of these key players suggests a dynamic environment where innovation and operational efficiency are paramount.
In October Stericycle (US) announced a significant investment in a new waste processing facility in Texas, aimed at increasing its capacity to handle pharmaceutical waste. This strategic move is likely to enhance its operational efficiency and reduce transportation costs, thereby improving service delivery to clients in the region. Such investments reflect a broader trend of companies seeking to bolster their infrastructure to meet rising demand.
In September Clean Harbors (US) launched a new line of eco-friendly waste disposal services tailored specifically for pharmaceutical manufacturers. This initiative not only aligns with the growing regulatory focus on sustainability but also positions Clean Harbors (US) as a leader in environmentally responsible waste management solutions. The introduction of these services may attract clients who prioritize sustainability in their operations, thereby enhancing Clean Harbors' competitive edge.
In August Veolia (FR) entered into a strategic partnership with a leading healthcare provider to develop a comprehensive waste management program that incorporates advanced recycling technologies. This collaboration is indicative of a trend towards integrated waste management solutions that not only address disposal but also emphasize resource recovery. Such partnerships may prove essential in navigating the complexities of pharmaceutical waste management while also driving innovation in the sector.
As of November the competitive trends in the pharmaceutical waste-management market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into operations. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing service offerings and operational capabilities. Looking ahead, it appears that competitive differentiation will increasingly hinge on innovation and technology, rather than solely on price. Companies that can effectively leverage these trends are likely to emerge as leaders in a market that is evolving rapidly.

## Recent News & Developments

Recent developments in the US Pharmaceutical Waste Management Market have seen a surge in regulatory scrutiny and innovations to improve waste management processes. With increasing awareness regarding the environmental impact of pharmaceutical waste, companies like MediWaste, Stericycle, and BioMedical Waste Solutions have been working on advanced waste treatment technologies to enhance compliance with stringent regulations. In terms of mergers and acquisitions, Covanta, a key player, acquired a waste management division that bolstered its capabilities in handling hazardous medical waste in August 2023. 

Additionally, Waste Management expanded its service offerings by acquiring a local medical waste disposal company in June 2023, enhancing its operational footprint. The market has witnessed substantial growth, with valuations for companies like Sharps Compliance and Clean Harbors increasing significantly due to the growing emphasis on sustainability and efficient waste handling. Regulatory bodies, including the Environmental Protection Agency, continue to emphasize the importance of managing pharmaceutical waste, influencing companies to adopt more innovative and environmentally friendly solutions. Market dynamics have been strongly shaped by these factors, ensuring a robust expansion trajectory in the coming years.

Over the past two to three years, the focus on legislative frameworks has only intensified, enhancing accountability across the industry.

## Report Scope

| MARKET SIZE 2024 | 275.27(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 295.01(USD Million) |
| MARKET SIZE 2035 | 589.73(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.17% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Veolia (FR), Stericycle (US), Clean Harbors (US), Waste Management (US), Republic Services (US), SUEZ (FR), Covanta (US), GFL Environmental (CA), Remondis (DE) |
| Segments Covered | Nature of Waste, Type of Waste, Source of Waste Generation |
| Key Market Opportunities | Adoption of advanced technologies for efficient pharmaceutical waste disposal and compliance with evolving regulations. |
| Key Market Dynamics | Regulatory pressures drive innovation and efficiency in pharmaceutical waste-management practices across the market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US pharmaceutical waste-management market in 2024?**
A: The market valuation was $275.27 Million in 2024.

**Q: What is the projected market valuation for the US pharmaceutical waste-management market by 2035?**
A: The projected valuation for 2035 is $589.73 Million.

**Q: What is the expected CAGR for the US pharmaceutical waste-management market during the forecast period 2025 - 2035?**
A: The expected CAGR during this period is 7.17%.

**Q: Which companies are considered key players in the US pharmaceutical waste-management market?**
A: Key players include Veolia, Stericycle, Clean Harbors, Waste Management, Republic Services, SUEZ, Covanta, GFL Environmental, and Remondis.

**Q: What are the two main segments of waste in the US pharmaceutical waste-management market?**
A: The two main segments are Non-hazardous Pharmaceutical Waste and Hazardous Pharmaceutical Waste.

**Q: What was the valuation of Non-hazardous Pharmaceutical Waste in 2024?**
A: The valuation of Non-hazardous Pharmaceutical Waste was $165.69 Million in 2024.

**Q: What is the projected valuation for Controlled Drugs in 2035?**
A: The projected valuation for Controlled Drugs in 2035 is $180.0 Million.

**Q: Which source of waste generation had the highest valuation in 2024?**
A: Hospitals had the highest valuation at $110.0 Million in 2024.

**Q: What is the projected valuation for Hazardous Drugs by 2035?**
A: The projected valuation for Hazardous Drugs by 2035 is $149.73 Million.

**Q: How does the valuation of Over the Counter Waste compare between 2024 and 2035?**
A: Over the Counter Waste was valued at $50.0 Million in 2024 and is projected to reach $110.0 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-pharmaceutical-waste-management-market-18940*